Hikarilevan Injections 200 ml for hepatic encephalopathy (amino acids, chronic liver disorders)

What are Hikarilevan Injections 200 ml for hepatic encephalopathy (amino acids, chronic liver disorders)?

Hikarilevan injections represent an advanced treatment option for individuals contending with hepatic encephalopathy, particularly in the context of chronic liver ailments. These amino acid injections are meticulously crafted to include vital elements like L-Threonine, L-Serine, L-Proline, L-Cysteine, Glycine, L-Alanine, L-Valine, L-Methionine, L-Isoleucine, L-Leucine, L-Phenylalanine, L-Tryptophan, L-Lysine, L-Histidine, and L-Arginine. This specialized blend of amino acids, featuring 35.5% branched-chain amino acids and a reduced ratio of aromatic amino acids and tryptophan, is tailored to specifically address the pathology of encephalopathy during hepatic failure.

Why Opt for Hikarilevan Injections for Hepatic Encephalopathy Treatment?

Treatment with Hikarilevan injections significantly enhances the amino acid profile in the bloodstream and brain, thereby improving metabolic abnormalities in the brain's monoamine system. This adjustment leads to substantial enhancements in cognitive and neurological functions for patients grappling with hepatic encephalopathy due to chronic liver conditions. The treatment notably enhances consciousness levels, reduces blood ammonia concentrations, and improves performance across various mental and neurological assessments.

Comprehensive Enhancement of Patient Outcomes

Hikarilevan injections offer significant benefits, including improved coma stages and reduced blood ammonia levels. Moreover, this treatment enhances performance in mental and neurological assessments such as writing and drawing tests, tremor assessments, connection tests, guidance tests, calculation tests, and electroencephalography results. These advancements underscore the comprehensive advantages of this treatment, establishing it as an indispensable option for individuals affected by hepatic encephalopathy stemming from chronic liver disorders.

Proven Benefits in Treating Chronic Liver Disorders

The efficacy of Hikarilevan injections extends across various types of hepatic encephalopathy, with studies demonstrating an average effectiveness rate of 70.4%. Notably, it shows a success rate of 73.3% for encephalopathy associated with hepatic cirrhosis, 62.2% for primary liver cancer encephalopathy, and 62.5% for other forms of the condition. These statistics highlight the reliable and broad-spectrum effectiveness of this treatment.

Scientific Validation and Strong Evidence Base

The scientific community recognizes the benefits of amino acid injections for treating hepatic encephalopathy, supported by high-quality evidence. Notably, research affirms the positive impact of these amino acids on hepatic encephalopathy, reinforcing the credibility and trustworthiness of Hikarilevan injections.

In summary, Hikarilevan injections offer a scientifically validated and highly effective treatment for hepatic encephalopathy. Their unique amino acid composition targets the specific needs of individuals with chronic liver disorders, delivering significant improvements in mental and neurological health. Consider this advanced treatment to benefit from its transformative effects on your health and overall quality of life.

Active principles: amino acid combination, including:

• L-Threonine,
• L-Serine,
• L-Proline,
• L-Cysteine,
• Glycine,
• L-Alanine,
• L-Valine,
• L-Methionine,
• L-Isoleucine,
• L-Leucine,
• L-Phenylalanine,
• L-Tryptophan,
• L-Lysine,
• L-histidine,
• L-arginine

Amount: 20 sachets * 200 ml

Indications: improvement of encephalopathy in chronic liver disorders

How to take: adults should receive 500-1000 ml intravenously. The standard administration rate for adults is 180-300 minutes per 500 ml. When using central venous infusion, 500-1000 ml of this product is mixed with a glucose infusion solution and continuously infused into the central vein over 24 hours. Your doctor may increase or decrease the dosage depending on your age, symptoms, and weight. For elderly patients, take care to slow down the administration rate and reduce the dosage.

Contraindications and precautions: Store in a dry cool place, out of reach of children. Do not use for children, pregnant or breastfeeding women. Do not use for patients with abnormal amino acid metabolism or severe renal impairment. Do not use for patients with severe acidosis or congestive heart failure. Patients should do their best to prevent getting infected while taking this medicine. Do not expose to sunlight or heat. If allergic symptoms occur, discontinue use.